National Institute of Biomedical Imaging and Bioengineering

We recently published a list of Top 8 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at where Nano-X Imaging Ltd. (NASDAQ:NNOX) stands against other top AI news updates investors should not miss.

BBB is already working with ethicists and regulatory experts to ensure its technology is developed responsibly.

The research regarding bone tissues comprises the development of new techniques ranging from medication administration, used to prevent and remediate bone

Another company involved in using AI to repurpose failed drugs - as well as drugs that have already been approved - is BioXcel Therapeutics. Unlike Ignota, however, the company focuses on compounds that have already demonstrated safety in prior clinical trials, but have been discontinued by their developers for various other reasons.

AI's impact on radiology and patient care discussed by experts at national conference, highlighting benefits and challenges.

A new National Academies report recommends ways for the U.S. to reap the benefits of artificial intelligence in biotechnology while minimizing risks that AI may be misused to develop harmful biological agents.

UNC Charlotte researchers are contributing to pioneering breakthroughs in cancer therapeutics, communicable disease forecasting and prevention, optical applications for health care, and use of AI and other innovative computational tools — and more.

Passive Brain-Computer Interfaces (pBCIs) have shown significant advancements in recent years, indicating their readiness for practical, everyday